Stock ALHC ALIGNMENT HEALTHCARE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Alignment Healthcare, Inc.

Equities

ALHC

US01625V1044

Market Closed - Nasdaq
Other stock markets
 01:30:00 27/04/2024 am IST 		5-day change 1st Jan Change
5.21 USD +0.97% Intraday chart for Alignment Healthcare, Inc. +0.19% -39.49%
23/04 Stifel Adjusts Alignment Healthcare's Price Target to $9 From $11, Maintains Buy Rating MT
08/03 Transcript : Alignment Healthcare, Inc. - Special Call

Evolution of the average Target Price on Alignment Healthcare, Inc.

Price target over the last 5 years

History of analyst recommendation changes

1c050624dd321ea722cf41ce418a7.fA4irb8Qf8Gy46oA9-ssqonLU4QqDR-pnJBd2u3agC8.SyNRw9hURojHp8B4n5tZmOSdF_BFXTLsxqMkk6iqt10-Og_g-yFInva2kg~a9bab3b7d705245ef0998ead37d4d625

Analyst Recommendations on Alignment Healthcare, Inc.

Stifel Adjusts Alignment Healthcare's Price Target to $9 From $11, Maintains Buy Rating MT
Piper Sandler Downgrades Alignment Healthcare to Neutral From Overweight, Adjusts Price Target to $6 From $12 MT
UBS Adjusts Alignment Healthcare Price Target to $8.50 From $9, Maintains Neutral Rating MT
Stifel Starts Coverage on Alignment Healthcare with Buy Rating, $11 Price Target MT
Stephens Adjusts Price Target on Alignment Healthcare to $10.50 From $9, Keeps Equalweight Rating MT
UBS Adjusts Alignment Healthcare Price Target to $9 From $6.50, Maintains Neutral Rating MT
BofA Securities Downgrades Alignment Healthcare to Neutral From Buy MT
Raymond James Upgrades Alignment Healthcare to Strong Buy From Outperform, Adjusts Price Target to $10 From $9 MT
Stephens Initiates Coverage on Alignment Healthcare with Equalweight Rating, $9 Price Target MT
Morgan Stanley Adjusts Alignment Healthcare's Price Target to $12 From $19, Keeps Overweight Rating MT
UBS Adjusts Alignment Healthcare Price Target to $6 From $8, Maintains Neutral Rating MT
JPMorgan Adjusts Price Target on Alignment Healthcare to $10 From $12, Maintains Neutral Rating MT
UBS Adjusts Alignment Healthcare Price Target to $8 From $10, Maintains Neutral Rating MT
Raymond James Upgrades Alignment Healthcare to Outperform From Market Perform, Price Target is $9 MT
Goldman Sachs Adjusts Alignment Healthcare Price Target to $12 From $14, Maintains Buy Rating MT
Goldman Sachs Adjusts Price Target on Alignment Healthcare to $14 From $21, Maintains Buy Rating MT
Piper Sandler Adjusts Price Target on Alignment Healthcare to $12 From $19, Maintains Overweight Rating MT
UBS Adjusts Alignment Healthcare's Price Target to $10 From $16, Maintains Neutral Rating MT
JPMorgan Downgrades Alignment Healthcare to Neutral From Overweight, Adjusts Price Target to $12 From $22 MT
Raymond James Downgrades Alignment Healthcare to Market Perform From Outperform MT
UBS Adjusts Alignment Healthcare Price Target to $16 From $17, Maintains Neutral Rating MT
Alignment Health Plan Receives Top Star Rating in North Carolina, High Marks for California Plan Quality GL
Alignment Health Plan Receives Top Star Rating in North Carolina, High Marks for California Plan Quality AQ
CVS Health, Centene lead health insurers lower after 2023 Medicare ratings RE
Piper Sandler Initiates Alignment Healthcare With Overweight Rating, $19 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
5.21 USD
Average target price
8 USD
Spread / Average Target
+53.55%
High Price Target
10 USD
Spread / Highest target
+91.94%
Low Price Target
4.5 USD
Spread / Lowest Target
-13.63%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Alignment Healthcare, Inc.

Stifel Nicolaus
Piper Sandler
UBS
Stephens Inc.
BofA Securities
Raymond James
Morgan Stanley
JPMorgan Chase
Goldman Sachs
Cowen
Barclays
SVB Leerink
William Blair & Co.

Ratings for Alignment Healthcare, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ALHC Stock
  4. Consensus Alignment Healthcare, Inc.